Related Experiment Video
Updated: Mar 30, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad
Xiaohua Yan1, Hongwei Liao2, Minzhang Cheng2
1From the State Key Laboratory of Membrane Biology, Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, 100084 China, yanxiaohua06@126.com.
Abstract:
TGF-β is a pleiotropic cytokine that regulates a wide range of cellular actions and pathophysiological processes. TGF-β signaling is spatiotemporally fine-tuned. As a key negative regulator of TGF-β signaling, Smad7 exerts its inhibitory effects by blocking receptor activity, inducing receptor degradation or interfering with Smad-DNA binding. However, the functions and the molecular mechanisms underlying the actions of Smad7 in TGF-β signaling are still not fully understood. In this study we report a novel mechanism whereby Smad7 antagonizes TGF-β signaling at the Smad level. Smad7 oligomerized with R-Smad proteins upon TGF-β signaling and directly inhibited R-Smad activity, as assessed by Gal4-luciferase reporter assays. Mechanistically, Smad7 competes with Smad4 to associate with R-Smads and recruits the E3 ubiquitin ligase NEDD4L to activated R-Smads, leading to their polyubiquitination and proteasomal degradation. Similar to the R-Smad-Smad4 oligomerization, the interaction between R-Smads and Smad7 is mediated by their mad homology 2 (MH2) domains. A positive-charged basic region including the L3/β8 loop-strand module and adjacent amino acids in the MH2 domain of Smad7 is essential for the interaction. These results shed new light on the regulation of TGF-β signaling by Smad7.
Insights
Smad7 inhibits Transforming Growth Factor-beta (TGF-β) signaling by directly binding to R-Smads, preventing Smad4 interaction and promoting R-Smad degradation via NEDD4L. This reveals a novel Smad-level regulatory mechanism for TGF-β.
Area of Science:
- Cellular Biology
- Molecular Biology
- Signal Transduction
Background:
- Transforming Growth Factor-beta (TGF-β) is a cytokine regulating diverse cellular processes.
- Smad7 is a known negative regulator of TGF-β signaling, but its precise mechanisms are not fully elucidated.
Purpose of the Study:
- To investigate novel molecular mechanisms by which Smad7 antagonizes TGF-β signaling at the Smad level.
Main Methods:
- Gal4-luciferase reporter assays were used to assess Smad7's inhibitory effects.
- Investigated protein-protein interactions between Smad7, R-Smads, Smad4, and NEDD4L.
- Utilized domain mapping to identify critical regions for Smad7-R-Smad interaction.
Main Results:
- Smad7 oligomerizes with R-Smads upon TGF-β signaling, directly inhibiting R-Smad activity.
- Smad7 competes with Smad4 for R-Smad binding and recruits NEDD4L for R-Smad polyubiquitination and proteasomal degradation.
- The Mad homology 2 (MH2) domain of Smad7, particularly a basic region within the L3/β8 loop-strand module, is crucial for R-Smad interaction.
Conclusions:
- Smad7 employs a novel mechanism to inhibit TGF-β signaling by directly targeting R-Smads.
- This interaction leads to R-Smad inactivation and degradation, offering new insights into TGF-β pathway regulation.
More Related Videos
11:38Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
Published on: September 14, 2021
07:49Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
Related Concept Videos
TGF - β Signaling Pathway
The JAK-STAT Signaling Pathway
Hedgehog Signaling Pathway
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Amplifying Signals via Enzymatic Cascade